G Li, B Jiang, Y Huang, J Shi, H Pan, H Shan… - … , Evaluation, and Dft … - papers.ssrn.com
Nirmatrelvir belongs to a class of drugs capable of targeting all current COVID-19 variants,
demonstrating promising application in the field of anti-COVID-19 variants therapy. This …